Genetic polymorphisms can significantly impact how individuals respond to inhibitors. Variations in enzyme genes can alter susceptibility to toxic substances, resulting in different toxicological outcomes. Personalized medicine approaches consider these genetic factors to optimize treatment and minimize adverse effects.
